Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: A pilot study-Reference-Cited by-同舟云学术

Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: A pilot study

Published:2016-03 Issue:3 Volume:35 Page:342-351
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Maron Bradley A.,Stephens Thomas E.,Farrell Laurie A.,Oldham William M.,Loscalzo Joseph,Leopold Jane A.,Lewis Gregory D.

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference25 articles.

1. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity;Leopold;Nat Med,2007

2. Direct regulation of blood pressure by smooth muscle mineralocorticoid receptors;McCurley;Nat Med,2012

3. Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells;Maron;J Biol Chem,2009

4. Aldosterone inactivates the endothelin-B receptor to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension;Maron;Circulation,2012

5. Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis;Maron;Circulation,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research;Frontiers in Cardiovascular Medicine;2023-01-30

2. Peptidergic G Protein–Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back;Endocrine Reviews;2022-04-18

3. Mineralocorticoid receptors in pulmonary hypertension and right heart failure: From molecular biology to therapeutic targeting;Pharmacology & Therapeutics;2022-03

4. Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension;Chest;2021-04

5. Angiotensin converting enzyme 2 and angiotensin (1–7) axis in pulmonary arterial hypertension;European Respiratory Journal;2020-04-02